John Munkhaugen

17PUBLICATIONS
75CO-AUTHORS
Computational physiologyBiomechanicsPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Time series and spatial modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 10, 2026
Risk-Score Guided Estimation of Absolute Benefit From Beta-blockers after Myocardial Infarction in Patients Without Heart Failure.

|Aug 11, 2026
Beta-blocker therapy and physical activity after myocardial infarction: a preplanned sub-study of the BETAMI trial.

|Jun 05, 2026
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.

|Apr 04, 2026
Validating national registry data for randomized trials: comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial.

Therese Lucia Friis Holmager, Anna Meta Dyrvig Kristensen, Morten Wang Fagerland

|Mar 16, 2026
Cardiac-related symptoms in individuals aged ≥65 years without diagnosed cardiac disease: insights from the NORSCREEN trial.

Jarle Jortveit, Miroslav Boskovic, Marius B Haraldsen

Pageof 3

Frequent Collaborators

5 joint publications

Dan Atar

4 joint publications

Elise Sverre

3 joint publications

Hanne Ellekjær

3 joint publications

Sigrun Halvorsen